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Spider silks have remarkable physical properties due to a
combination of strength and elasticity. In addition, spider silks
are biocompatible and biodegradable. Our laboratory has
shown that the strength of products, such as fibers, produced
with other silk proteins correlates with the size of the silk
protein. The aciniform silk protein (AcSp1), has been shown
to produce the thinnest and strongest fibers of all the natural
spider silks. Aciniform silk is composed of a nonrepetitive
amino-terminal region, 14 repeats of approximately 200
amino acids each, and a nonrepetitive carboxy-terminal
region. We have been able to produce different variants of this
gene. All AcSp1 protein variants were able to express in
E. coli. The bacteria expression of the AcSp1 protein is low
and the protein is expressed not only as a full length
polypeptide but also as fragments of the protein. We identified
a sequence in the amino-terminal region of the first repeat of
the AcSp1 gene that acts as an early termination sequence.
Our objective is to modify this region on the gene to study
changes in the expression efficiency of AcSp1.

An Aciniform gene was synthesized based on its
protein sequence. The synthetic gene encodes for two
identical repeats. Two new variants of the gene were
generated by site directed mutagenesis which was
performed using single stranded DNA (ssDNA).
Two oligonucleotides (LoFi and NT1) were designed
to introduce several mutations in the synthetic gene.

We have generated two variants of the AcSp1 synthetic gene:
LoFi and NT1. Both variants have a much higher expression
than the original synthetic gene (Fig. 3). The changes have not
reduced the number of additional incomplete polypeptides.
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First repeat
Second repeat
NT1

LoFi NT1

High-usage (ratio) codons replaced by low-usage codons
Original sequence
Ratio 0.27 0.43 0.43 0.13 0.38 0.22 0.70 0.27
5' AGC ACC ACC AGT GGT GCA GAA AGC 3'
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LoFi mutant
Ratio 0.13 0.13 0.21
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5' AGT ACT ACT AGT GGG GCA GAA AGT 3'
S
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N-terminus of second repeat replaced by N-terminus of first
repeat
Original sequence
5' GGC GGT TAT CCT GGC GGT TAC CCA GGC GGA 3‘
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NT1 mutant
5' GGT GGT TAT CCG GGT GGC TAT CCT GGT GGT 3'
G
G
Y
P
G
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Y
P
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Figure 3. Western Blot of Aciniform 2 repeats. Lanes 1: MW markers,
2: AcSp1 synthetic gene 2 repeats, 3: AcSp1 LoFi mutant, 4: AcSp1
NT1 mutant. Samples were standardized by optical density (OD600).
Arrow indicates full length AcSp1.

Conclusions
•The strategy to convert high-usage codons into
low-usage codons by E. coli increased the efficiency
of AcSp1 expression in variant LoFi.
•Replacing the sequence of the N-terminus of the
second repeat by the one of the first repeat resulted in
a much higher expression of AcSp1 (NT1).

B
MGHHHHHHHHHHSSGHIDDDDKHMTGGYPGGYPGGQGAGPLGGVPLVSQSLDNLGG
GGAQAGLISRVANALANTSTLRAVLRRGVSQNTVNNVVQRTVQSLANTLGVDGNNLAR

•Neither variant shows a reduction of the number of
partial-length polypeptides of AcSp1.

IASQAISQVPAGSDTNAYAQALSTANLVTGGILNERNIDSLGSRVLSAVLNGVSSAAQGL
GINVDTGNLQGDIRSSTGFLSTGSSSTILSQTAASTTSGAESTSGGYPGGYPGGQGAGP
LGGVPLVSPSLDNLGGGGAQAGLISRVANALANTSTLRAVLRRGVSQNTVNNVVQRTV
QSLANTLGVDGNNLARIASQAISQVPAGSDTNAYAQALSTANLVTGGILNERNIDSLGSR
VLSAVLNGVSSAAQGLGINVDTGNLQGDIRSSTGFLSTGSSSTILSQTAASTTSGAET

Figure 1: A) Mass Spectrometry chromatograph of the
purified truncated polypeptide. The major peak indicates its
molecular mass and allowed us to determine the sequence of
the polypeptide. B) AcSp1 protein sequence (2 repeats) and
site of early protein synthesis termination (red arrow).

AcSp1
Figure 2: Model represents the site where the mRNA
stalls during translation, resulting in an early termination
of protein synthesis. Stars indicate sites modified by
mutagenesis.

Future work
Future work remains to be done in order to increase the
expression of a full length protein.
•Study additional domains of the gene by mutagenesis.
•Express AcSp1 proteins with higher number of repeats.

